Clinical trials benefit the health and safety of patients by making proven new treatments available more quickly. This industry is also very important for the UK economy. However, recent years have seen a drop in the number of trials held in the UK. This POSTnote summarises some of the most important reasons behind this decline, and the actions being taken to improve the situation. It also highlights areas identified by key industry partners as opportunities for growth.